CohBar Announces Acceptance of Late Breaking Abstract on its Antifibrotic Peptides at The American Thoracic Society 2020 International Conference Apr 14, 2020
CohBar to Announce 2019 Fourth Quarter Financial Results and Provide Business Update on March 12, 2020 Mar 2, 2020
CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis Jan 8, 2020
CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis Dec 16, 2019
